Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants
- PMID: 178852
- DOI: 10.1016/s0022-3476(76)81044-x
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants
Abstract
Respiratory syncytial virus ts-1 is a live attenuated experimental vaccine which was administered intranasally to 25 infants 11 to 19 months of age. Clinical evaluation was carried out following a controlled, double-blind protocol which eliminated observer bias, assessed intercurrent illness, and was designed to detect virus transmission. At the low dose of virus of virus used (100 TCID50) 8 of the 25 recipients were successfully infected with RS virus ts-1 as determined by virus shedding or antibody response.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
